• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COCHLEAR LTD NUCLEUS HYBRID L24; NUCLEUS 24 COCHLEAR IMPLANT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COCHLEAR LTD NUCLEUS HYBRID L24; NUCLEUS 24 COCHLEAR IMPLANT SYSTEM Back to Search Results
Model Number CI24RE (L24)
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Hearing Impairment (1881)
Event Date 12/09/2019
Event Type  Injury  
Manufacturer Narrative
This report is submitted on december 31, 2019.
 
Event Description
Per the clinic, the patient experienced poor performance with the device.Reprogramming attempts were made; however, the issue could not be resolved.The device was explanted (b)(6) 2019.It is unknown if the patient has been re-implanted with another device.
 
Manufacturer Narrative
This report is submitted on 23 march 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NUCLEUS HYBRID L24
Type of Device
NUCLEUS 24 COCHLEAR IMPLANT SYSTEM
Manufacturer (Section D)
COCHLEAR LTD
1 university avenue
macquarie university, 2109
AS  2109
MDR Report Key9533682
MDR Text Key173186812
Report Number6000034-2019-02966
Device Sequence Number1
Product Code MCM
UDI-Device Identifier09321502012089
UDI-Public(01)09321502012089(11)161108(17)181107
Combination Product (y/n)N
PMA/PMN Number
P130016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/31/2019,02/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/07/2018
Device Model NumberCI24RE (L24)
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA12/31/2019
Date Report to Manufacturer12/09/2019
Initial Date Manufacturer Received 12/09/2019
Initial Date FDA Received12/30/2019
Supplement Dates Manufacturer Received02/25/2020
Supplement Dates FDA Received03/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
-
-